Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010

Luca Malcovati, Régis Peffault de Latour, Antonio Risitano

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematological disorders belonging to the Bone Marrow Failure (BMF) syndromes. The Aplastic Anemia and Myelodysplastic Syndromes International Foundation (AA&MDSIF) is a non-profit organization dedicated to supporting patients and families living with a BMF disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from the last AA&MDSIF scientific symposium held in Bethesda, Maryland on March 2010.

Original languageEnglish
Pages (from-to)291-294
Number of pages4
JournalLeukemia Research
Volume35
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

Bone Marrow Diseases
Aplastic Anemia
Myelodysplastic Syndromes
Nonprofit Organizations
Research Personnel

Keywords

  • Aplastic anemia
  • Bone marrow failure
  • Complement
  • Epigenetic therapy
  • Immunosuppressive therapy
  • Myelodysplastic syndromes
  • Paroxysmal nocturnal hemoglobinuria
  • Stem cell transplantation

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Aplastic Anemia & MDS International Foundation (AA&MDSIF) : Bone Marrow Failure Disease Scientific Symposium 2010. / Malcovati, Luca; de Latour, Régis Peffault; Risitano, Antonio.

In: Leukemia Research, Vol. 35, No. 3, 03.2011, p. 291-294.

Research output: Contribution to journalArticle

@article{b70144939b82460d8d79a7a9e1d29756,
title = "Aplastic Anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010",
abstract = "Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematological disorders belonging to the Bone Marrow Failure (BMF) syndromes. The Aplastic Anemia and Myelodysplastic Syndromes International Foundation (AA&MDSIF) is a non-profit organization dedicated to supporting patients and families living with a BMF disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from the last AA&MDSIF scientific symposium held in Bethesda, Maryland on March 2010.",
keywords = "Aplastic anemia, Bone marrow failure, Complement, Epigenetic therapy, Immunosuppressive therapy, Myelodysplastic syndromes, Paroxysmal nocturnal hemoglobinuria, Stem cell transplantation",
author = "Luca Malcovati and {de Latour}, {R{\'e}gis Peffault} and Antonio Risitano",
year = "2011",
month = "3",
doi = "10.1016/j.leukres.2010.10.010",
language = "English",
volume = "35",
pages = "291--294",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Ltd",
number = "3",

}

TY - JOUR

T1 - Aplastic Anemia & MDS International Foundation (AA&MDSIF)

T2 - Bone Marrow Failure Disease Scientific Symposium 2010

AU - Malcovati, Luca

AU - de Latour, Régis Peffault

AU - Risitano, Antonio

PY - 2011/3

Y1 - 2011/3

N2 - Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematological disorders belonging to the Bone Marrow Failure (BMF) syndromes. The Aplastic Anemia and Myelodysplastic Syndromes International Foundation (AA&MDSIF) is a non-profit organization dedicated to supporting patients and families living with a BMF disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from the last AA&MDSIF scientific symposium held in Bethesda, Maryland on March 2010.

AB - Aplastic anemia (AA) and myelodysplastic syndromes (MDS) are a heterogeneous group of rare hematological disorders belonging to the Bone Marrow Failure (BMF) syndromes. The Aplastic Anemia and Myelodysplastic Syndromes International Foundation (AA&MDSIF) is a non-profit organization dedicated to supporting patients and families living with a BMF disease. They work to bring investigators together in a collaborative manner. This article summarizes key presentations from the last AA&MDSIF scientific symposium held in Bethesda, Maryland on March 2010.

KW - Aplastic anemia

KW - Bone marrow failure

KW - Complement

KW - Epigenetic therapy

KW - Immunosuppressive therapy

KW - Myelodysplastic syndromes

KW - Paroxysmal nocturnal hemoglobinuria

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=79952100873&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952100873&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2010.10.010

DO - 10.1016/j.leukres.2010.10.010

M3 - Article

C2 - 21036397

AN - SCOPUS:79952100873

VL - 35

SP - 291

EP - 294

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 3

ER -